There is a shortage of critical medicines in the European Union (EU), said Member of the European Parliament (EP) from Poland Bartosz Arlukowicz. The MEP raised the corresponding problem as part of an appeal to the European Commission (EC).
As Day.Az reports, the text of the corresponding letter was studied by lenta.ru.
“Shortages of essential medicines on the European market are a serious problem that affects the health and safety of patients. Medicines used to treat chronic diseases, rare diseases and emergency situations, such as oncology drugs and painkillers, are particularly difficult to obtain. The consequences of shortages of key medicines could be catastrophic, ranging from delays in treatment to an increase in patient mortality,” the parliamentarian said.
In addition, he recalled that in December 2023, the European Commission published a list of 200 medicines that are critical in the EU. In this regard, Arlukovic asks the EC a number of questions.
“What specific measures has the European Commission taken to combat shortages of these medicines since the publication of the list of essential medicines? For which medicines and in which EU Member States has the Commission noted shortages since December 2023, what measures have been taken to eliminate them?” – he asked.